Gyre Therapeutics, Inc.

GYRE • NASDAQ • Stock Fundamentals

Gyre Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ping Zhang, with a market cap of $588.0M.

Market Cap$588.0M

Employees391.0

CEOPing Zhang

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026

Next EarningsAug 10, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Gyre Therapeutics, Inc.

Gyre Therapeutics, Inc. (GYRE) has a market capitalization of $588.0M and trades on NASDAQ.

Gyre Therapeutics, Inc. has approximately 391 employees.